LabVantage Release Labvantage 8
News Feb 22, 2016
LabVantage Solutions has announced the release of the latest, most powerful version of its solution, LabVantage 8. A configurable, web-based solution, LabVantage is used by companies worldwide to automate their laboratory processes and strategically transform their businesses.
The newest version includes new capabilities that enable laboratories to operate with even greater efficiency, effectiveness and quality.
“Among the many advances in LabVantage 8, you will see a new user interface—developed with extensive customer input—that greatly enhances usability,” said Peter Bailey, Chief Executive Officer at LabVantage Solutions.
“As we celebrate our 35th year of leadership in the LIMS industry, the introduction of LabVantage 8 is a testament to the innovation that we have brought, and will continue to bring, to the market. Our goal is simple: we want our customers to have the type of solution that helps them grow their businesses.”
In addition to a new user interface, LabVantage 8 includes several new enhancements designed to increase efficiency, including an improved design for viewing and managing critical data making it quicker to access and intuitive to use. A new scheduler interface features a calendar view, schedule randomization and local time zone support.
Other highlights include a new, end-to-end formulations solution that manages compound recipes. For the Biobanking industry, LabVantage 8 incorporates a new accessioning feature that greatly simplifies and integrates sample allocation, as well as a consent management feature that enforces compliance in the subject’s sample usage for studies.
For scientists wrestling with problems as diverse as containing superhot plasma in a fusion reactor, improving the accuracy of weather forecasts, or probing the unexplained dynamics of a distant galaxy, turbulence-spawning shear flow is a serious complicating factor. A new supercomputer-powered effort aims to make modelling shear far easier.
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019